Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiwen Deng

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|May 3, 2005
Vasoactive prostanoids are generated from arachidonic acid by COX-1 and COX-2 in the mouseSyed R Baber, Weiwen Deng, Jorge Rodriguez, et al.
Advances in Immunology|February 11, 2014
Recognition of tumors by the innate immune system and natural killer cellsAssaf Marcus, Benjamin G Gowen, Thornton W Thompson, et al.
Blood|January 31, 2009
Intravenous administration of mesenchymal stem cells genetically modified with extracellular superoxide dismutase improves survival in irradiated miceAly S Abdel-Mageed, Anthony J Senagore, Daniel W Pietryga, et al.
Canadian Journal of Physiology and Pharmacology|August 11, 2005
Potential application for mesenchymal stem cells in the treatment of cardiovascular diseasesBruce A Bunnell, Weiwen Deng, Christine M Robinson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 19, 2006
Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunctionSyed R Baber, Weiwen Deng, Ryan G Master, et al.
Science (New York, N.Y.)|March 7, 2015
Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejectionWeiwen Deng, Benjamin G Gowen, Li Zhang, et al.
Journal of Medical Genetics|January 5, 2023
Variants in <i>BSN</i> gene associated with epilepsy with favourable outcomeTingting Ye, Jiwei Zhang, Jie Wang, et al.
Nature Immunology|March 18, 2008
TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradationMude Shi, Weiwen Deng, Enguang Bi, et al.
Cell Research|March 18, 2009
Novel function of perforin in negatively regulating CD4(+) T cell activation by affecting calcium signalingEnguang Bi, Chunjian Huang, Yu Hu, et al.
The Journal of Clinical Investigation|October 21, 2014
Cytokine therapy reverses NK cell anergy in MHC-deficient tumorsMichele Ardolino, Camillia S Azimi, Alexandre Iannello, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
American Journal of Physiology. Heart and Circulatory Physiology|May 3, 2005
Vasoactive prostanoids are generated from arachidonic acid by COX-1 and COX-2 in the mouseSyed R Baber, Weiwen Deng, Jorge Rodriguez, et al.
Advances in Immunology|February 11, 2014
Recognition of tumors by the innate immune system and natural killer cellsAssaf Marcus, Benjamin G Gowen, Thornton W Thompson, et al.
Blood|January 31, 2009
Intravenous administration of mesenchymal stem cells genetically modified with extracellular superoxide dismutase improves survival in irradiated miceAly S Abdel-Mageed, Anthony J Senagore, Daniel W Pietryga, et al.
Canadian Journal of Physiology and Pharmacology|August 11, 2005
Potential application for mesenchymal stem cells in the treatment of cardiovascular diseasesBruce A Bunnell, Weiwen Deng, Christine M Robinson, et al.
American Journal of Physiology. Heart and Circulatory Physiology|September 19, 2006
Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunctionSyed R Baber, Weiwen Deng, Ryan G Master, et al.
Science (New York, N.Y.)|March 7, 2015
Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejectionWeiwen Deng, Benjamin G Gowen, Li Zhang, et al.
Journal of Medical Genetics|January 5, 2023
Variants in <i>BSN</i> gene associated with epilepsy with favourable outcomeTingting Ye, Jiwei Zhang, Jie Wang, et al.
Nature Immunology|March 18, 2008
TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradationMude Shi, Weiwen Deng, Enguang Bi, et al.
Cell Research|March 18, 2009
Novel function of perforin in negatively regulating CD4(+) T cell activation by affecting calcium signalingEnguang Bi, Chunjian Huang, Yu Hu, et al.
The Journal of Clinical Investigation|October 21, 2014
Cytokine therapy reverses NK cell anergy in MHC-deficient tumorsMichele Ardolino, Camillia S Azimi, Alexandre Iannello, et al.
Pageof 4